Cargando…

Prostate cancer screening with prostate-specific antigen: A guide to the guidelines

BACKGROUND: Prostate cancer remains the most common non-skin cancer malignancy in men. Prostate-specific antigen (PSA) is recognized as a biomarker for the diagnosis, monitoring, and risk prediction of prostate cancer. Its use in the setting of prostate cancer screening has been controversial due to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabarkapa, Sonja, Perera, Marlon, McGrath, Shannon, Lawrentschuk, Nathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Pacific Prostate Society 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153437/ https://www.ncbi.nlm.nih.gov/pubmed/27995110 http://dx.doi.org/10.1016/j.prnil.2016.09.002

Ejemplares similares

Prostate cancer biomarkers: Are we hitting the mark?
por: McGrath, Shannon, et al.
Publicado: (2016)

Reporting and ideal testosterone levels in men undergoing androgen deprivation for prostate cancer—time for a rethink?
por: Cabarkapa, Sonja, et al.
Publicado: (2018)

Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies
por: Christidis, Daniel, et al.
Publicado: (2017)

(68)Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends
por: Udovicich, Cristian, et al.
Publicado: (2017)

Incidental prostate cancer in transurethral resection of prostate specimens in men aged up to 65 years
por: Perera, Marlon, et al.
Publicado: (2016)

Updates of prostate cancer staging: Prostate-specific membrane antigen
por: Sathianathen, Niranjan J, et al.
Publicado: (2016)

Gene‒Prostate-Specific-Antigen-Guided Personalized Screening for Prostate Cancer
por: Yang, Teng-Kai, et al.
Publicado: (2019)

Prostate-specific antigen-based screening: controversy and guidelines
por: Kim, Eric H, et al.
Publicado: (2015)

Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
por: Tikkinen, Kari A O, et al.
Publicado: (2018)

Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing
por: Jackson, Sherena D, et al.
Publicado: (2022)

Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?
por: Ong, Sean, et al.
Publicado: (2022)

Advice About Screening for Prostate Cancer With Prostate-Specific Antigen
por: Jean-Pierre, Gannel
Publicado: (2017)

Optimising patient outcomes with photoselective vaporization of the prostate (PVP): a review
por: Pascoe, Claire, et al.
Publicado: (2017)

Bioimpedance and chronoamperometry as an adjunct to prostate-specific antigen screening for prostate cancer
por: de Abreu, Darci Schiavon
Publicado: (2011)

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
por: Heijnsdijk, E A M, et al.
Publicado: (2009)

Prostate-Specific Antigen Screening and Recent Increases in Advanced Prostate Cancer
por: Nyame, Yaw A, et al.
Publicado: (2020)

Beyond Prostate Specific Antigen: New Prostate Cancer Screening Options
por: Narain, Tushar Aditya, et al.
Publicado: (2022)

Prostate cancer nodal oligometastasis accurately assessed using prostate-specific membrane antigen positron emission tomography-computed tomography and confirmed histologically following robotic-assisted lymph node dissection
por: O’Kane, Dermot B., et al.
Publicado: (2016)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial
por: Määttänen, L, et al.
Publicado: (2007)

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)
por: Stephan, Carsten, et al.
Publicado: (2014)

Screening for prostate cancer: a study on the free and total prostate specific antigen
por: Mediu, Ridvana, et al.
Publicado: (2021)

Prostate-specific antigen screening for prostate cancer: An old but never-ending story
por: Kim, Sun Il
Publicado: (2023)

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma
por: Udovicich, Cristian, et al.
Publicado: (2022)

Discoveries and application of prostate-specific antigen, and some proposals to optimize prostate cancer screening
por: Tokudome, Shinkan, et al.
Publicado: (2016)

Adding free to total prostate-specific antigen levels in trials of prostate cancer screening
por: Wald, N J, et al.
Publicado: (2000)

Is Prostate-Specific Antigen Effective for Population Screening of Prostate Cancer? A Systematic Review
por: Lee, Yoon Jae, et al.
Publicado: (2013)

The Value of Prostate-Specific Antigen-Related Indexes and Imaging Screening in the Diagnosis of Prostate Cancer
por: Bai, Xiaojing, et al.
Publicado: (2020)

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
por: Mikropoulos, Christos, et al.
Publicado: (2018)

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
por: Mikropoulos, Christos, et al.
Publicado: (2018)

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan
por: Kitagawa, Yasuhide, et al.
Publicado: (2014)

Active surveillance in intermediate risk prostate cancer: is it safe?
por: Krishnananthan, Nishanth, et al.
Publicado: (2016)

Recent advances in magnetic resonance imaging of prostate cancer
por: Lawrentschuk, Nathan, et al.
Publicado: (2010)

Quality of Health Information on the Internet for Prostate Cancer
por: Chang, Dwayne T. S., et al.
Publicado: (2018)

Irreversible Electroporation for Prostate Cancer
por: Ong, Sean, et al.
Publicado: (2021)

Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam
por: Wever, Elisabeth M., et al.
Publicado: (2010)

Lifetime Benefits and Harms of Prostate-Specific Antigen–Based Risk-Stratified Screening for Prostate Cancer
por: Heijnsdijk, Eveline A M, et al.
Publicado: (2020)

Active surveillance versus nonradical treatment for low-risk men with prostate cancer: a review
por: Perera, Sachin, et al.
Publicado: (2022)

Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer–Specific Mortality
por: Burgess, Laura, et al.
Publicado: (2022)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1a0s21ahbto5c21llo7k72nm2c